serine protease inhibitors (Dendreon/Dyax)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameserine protease inhibitors (Dendreon/Dyax)
Drug Alias Nameendotheliase inhibitors (Dendreon/Dyax)matriptase inhibitors (Dendreon)CVS-3983
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuppressor of tumorigenicity 14 protein inhibitors
TargetsSuppressor of tumorigenicity 14 protein
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon San Diego Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon San Diego LlcDyax Corp
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A